Clinical Trials Logo

Trichomonal Vaginitis clinical trials

View clinical trials related to Trichomonal Vaginitis.

Filter by:
  • None
  • Page 1

NCT ID: NCT06056947 Completed - Bacterial Vaginosis Clinical Trials

Evaluation of Efficacy and Safety of Two New Formulations Compared to Gynomax® XL Ovule

One-Shot
Start date: July 20, 2020
Phase: Phase 3
Study type: Interventional

Efficacy and safety of two new formulations compared to Gynomax® XL ovule in the treatment of trichomonal vaginitis, bacterial vaginosis, candidal vulvovaginitis and mixed vaginal infections was evaluated in this randomized, three-arms, multicentral study.

NCT ID: NCT03839875 Completed - Bacterial Vaginosis Clinical Trials

Evaluation of Efficacy and Safety of Gynomax® XL Ovule

Gyno-Türk
Start date: April 3, 2019
Phase: Phase 4
Study type: Interventional

Efficacy and safety of Gynomax® XL ovule in the treatment of trichomonal vaginitis, bacterial vaginosis, candidal vulvovaginitis and mixed vaginal infections will be evaluated in this open label, single-arm, multicentral study.

NCT ID: NCT01335373 Completed - Bacterial Vaginosis Clinical Trials

Observational Program Neo-Penotran® Forte

Start date: October 2010
Phase: N/A
Study type: Observational

Vaginitis is the most common gynecologic diagnosis in the primary care setting. In approximately 90 percent of affected women, this condition occurs secondary to bacterial vaginosis, vulvovaginal candidiasis, trichomoniasis or mixed infection. Neo-Penotran Forte is registered for treatment of these most common vaginal infections. Efficacy and safety of this product is already established, and this observational study was designed to learn more about practical use of Neo-Penotran® Forte in real life setting.